This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
mental health | 649 |
public health | 518 |
health care | 507 |
summary conclusions | 468 |
blood donors | 362 |
health services | 331 |
blood group | 228 |
blood transfusion | 210 |
whole blood | 192 |
blood donation | 190 |
red blood | 167 |
social media | 164 |
service providers | 148 |
service industries | 143 |
food delivery | 139 |
online food | 132 |
service provider | 130 |
red cell | 130 |
healthcare services | 126 |
customer engagement | 123 |
blood components | 121 |
health service | 119 |
blood bank | 116 |
smart service | 114 |
blood products | 114 |
blood cells | 108 |
delivery service | 105 |
hong kong | 104 |
blood donor | 103 |
customer service | 97 |
primary care | 90 |
service delivery | 85 |
psychological service | 84 |
blood cell | 84 |
transfusion reactions | 83 |
health system | 78 |
usage satisfaction | 76 |
health systems | 74 |
service system | 73 |
service systems | 73 |
smart product | 72 |
service users | 70 |
risk factors | 70 |
pregnant women | 68 |
health problems | 68 |
climate change | 68 |
systematic review | 67 |
platelet concentrates | 66 |
service use | 66 |
mobile payments | 66 |
developing countries | 65 |
red cells | 65 |
national health | 63 |
machine learning | 62 |
video consultations | 62 |
psychological services | 61 |
hiv aids | 60 |
united states | 59 |
transfusion medicine | 58 |
world health | 58 |
public transport | 58 |
adverse events | 57 |
service industry | 57 |
blood donations | 57 |
customer well | 56 |
blood supply | 54 |
healthcare service | 53 |
abstract withdrawn | 53 |
health organization | 53 |
control group | 53 |
care system | 52 |
inner city | 52 |
logistics services | 52 |
significantly higher | 51 |
present study | 51 |
flow cytometry | 50 |
new york | 49 |
camh services | 48 |
information technology | 48 |
statistically significant | 48 |
health promotion | 47 |
care services | 47 |
producer services | 47 |
health status | 47 |
stem cell | 46 |
health needs | 46 |
donor selection | 46 |
blood services | 45 |
ng ml | 45 |
antibody screening | 45 |
cord uid | 44 |
community pharmacists | 44 |
platelet count | 44 |
doc id | 44 |
first time | 44 |
blood banks | 44 |
data collection | 44 |
adverse reactions | 43 |
blood product | 43 |
big data | 43 |
clinical practice | 43 |
total number | 42 |
privacy concerns | 42 |
offline retail | 42 |
time donors | 42 |
telehealth services | 42 |
future research | 42 |
mental illness | 42 |
antigen expression | 42 |
performed using | 41 |
higher levels | 41 |
iu ml | 41 |
technology acceptance | 40 |
blood service | 40 |
climate services | 40 |
age group | 40 |
health policy | 40 |
logistics service | 39 |
trima accel | 39 |
health outcomes | 39 |
blood samples | 39 |
health conditions | 39 |
urban areas | 39 |
artificial intelligence | 39 |
services provided | 38 |
rural areas | 38 |
transfusion service | 38 |
national blood | 38 |
precision medicine | 38 |
supply chain | 38 |
community health | 37 |
food outlets | 37 |
substance use | 37 |
infectious diseases | 37 |
group system | 37 |
poster sessions | 37 |
hematopoietic stem | 37 |
health insurance | 37 |
ferritin levels | 36 |
literature review | 36 |
primary health | 36 |
years old | 36 |
prepared away | 36 |
iron deficiency | 36 |
population health | 35 |
health information | 35 |
repeat donors | 35 |
clinically significant | 35 |
tradable services | 35 |
blood collection | 35 |
high risk | 35 |
logistic regression | 34 |
blood safety | 34 |
case study | 34 |
significant difference | 34 |
rhd gene | 34 |
blood component | 34 |
smart products | 34 |
large number | 33 |
land use | 33 |
street youth | 33 |
focus group | 33 |
data analysis | 33 |
music therapy | 33 |
decision making | 33 |
focus groups | 32 |
services industry | 32 |
urban service | 32 |
climate service | 32 |
significant differences | 32 |
infection control | 31 |
drug use | 31 |
labor cost | 31 |
information systems | 31 |
quality control | 31 |
san francisco | 31 |
room temperature | 31 |
least one | 30 |
healthcare facilities | 30 |
cloud services | 30 |
specialized service | 30 |
abortion services | 30 |
will need | 30 |
female donors | 30 |
cfu ml | 30 |
blood units | 30 |
unit labor | 30 |
effi ciency | 30 |
urban health | 30 |
two groups | 29 |
wide range | 29 |
income countries | 29 |
transfusion services | 29 |
may also | 29 |
data collected | 29 |
privacy concern | 29 |
blood groups | 29 |
breast cancer | 29 |
social networks | 29 |
service co | 29 |
red cross | 28 |
side effects | 28 |
content analysis | 28 |
scenario planning | 28 |
general population | 28 |
lg ml | 28 |
delivery services | 28 |
specialized services | 28 |
mobile payment | 28 |
monoclonal antibody | 28 |
transfusion reaction | 28 |
blood transfusions | 28 |
drug users | 28 |
payments services | 28 |
retail smes | 28 |
service quality | 28 |
sickle cell | 28 |
mean age | 28 |
blood centers | 28 |
social justice | 28 |
health professionals | 28 |
mental disorders | 27 |
hb levels | 27 |
health centre | 27 |
basic public | 27 |
past days | 27 |
smart fridge | 27 |
male donors | 27 |
terumo bct | 27 |
services research | 27 |
urban development | 27 |
service level | 26 |
policy makers | 26 |
study period | 26 |
informed consent | 26 |
private sector | 26 |
food prepared | 26 |
technology anxiety | 26 |
hemolytic transfusion | 26 |
medical care | 26 |
working group | 26 |
higher risk | 26 |
quality assurance | 26 |
existing literature | 26 |
group antigens | 26 |
human resources | 26 |
low hb | 26 |
abo blood | 26 |
community members | 26 |
per year | 26 |
study aimed | 25 |
information system | 25 |
hiv infection | 25 |
patient safety | 25 |
positive results | 25 |
essential public | 25 |
i will | 25 |
iron supplementation | 25 |
safe blood | 25 |
family members | 25 |
travel time | 25 |
resource allocation | 25 |
adolescent mental | 25 |
south africa | 25 |
regression analysis | 25 |
community pharmacy | 25 |
genomic dna | 25 |
service customers | 25 |
antiglobulin test | 25 |
risk factor | 25 |
personal information | 25 |
health issues | 24 |
high levels | 24 |
health department | 24 |
rhd genotyping | 24 |
community pharmacies | 24 |
deep learning | 24 |
information privacy | 24 |
public services | 24 |
many countries | 24 |
clinical trials | 24 |
health sector | 24 |
social distancing | 24 |
platelet function | 24 |
blood pressure | 24 |
health interventions | 24 |
sectional study | 24 |
rbc units | 24 |
autologous blood | 24 |
perceived personalization | 24 |
statistical analysis | 24 |
high level | 24 |
last years | 24 |
immune system | 24 |
economic development | 24 |
sanger sequencing | 24 |
blood center | 24 |
widely used | 24 |
service provision | 23 |
care providers | 23 |
among blood | 23 |
intrusiveness sensitivity | 23 |
low income | 23 |
significantly lower | 23 |
transfusion safety | 23 |
rhd negative | 23 |
perceived intrusiveness | 23 |
retrospective analysis | 23 |
transmitted infections | 23 |
social capital | 23 |
los angeles | 23 |
will also | 23 |
behavioral engagement | 23 |
labor productivity | 23 |
cell disease | 23 |
smart services | 23 |
service levels | 22 |
pilot study | 22 |
advanced services | 22 |
healthcare providers | 22 |
healthcare system | 22 |
long term | 22 |
new technology | 22 |
dna samples | 22 |
eye care | 22 |
hb content | 22 |
sociodemographic characteristics | 22 |
column agglutination | 22 |
growth rates | 22 |
business rules | 22 |
presentation will | 22 |
social services | 22 |
determine whether | 22 |
patients undergoing | 22 |
rbc transfusion | 22 |
important role | 22 |
will provide | 22 |
bone marrow | 21 |
platelet content | 21 |
positive donations | 21 |
new public | 21 |
service sector | 21 |
platelet transfusion | 21 |
social support | 21 |
storage period | 21 |
increased risk | 21 |
development within | 21 |
business model | 21 |
suitable sites | 21 |
special issue | 21 |
service utilization | 21 |
intensive care | 21 |
reference laboratory | 21 |
clinically relevant | 21 |
social care | 21 |
two decades | 21 |
medical services | 20 |
health workers | 20 |
donor samples | 20 |
acute respiratory | 20 |
public policy | 20 |
plasma units | 20 |
donor deferral | 20 |
case studies | 20 |
southeast asia | 20 |
generated content | 20 |
blood grouping | 20 |
transfusion associated | 20 |
urban poor | 20 |
cell transplantation | 20 |
aged years | 20 |
video consultation | 20 |
transfusion therapy | 20 |
blood management | 20 |
cell units | 20 |
research questions | 19 |
socioeconomic status | 19 |
customer satisfaction | 19 |
median age | 19 |
hemolytic disease | 19 |
scenario development | 19 |
age groups | 19 |
tertiary care | 19 |
health facilities | 19 |
dental services | 19 |
electronic health | 19 |
qualitative data | 19 |
acceptance model | 19 |
critical care | 19 |
perceived stress | 19 |
private practice | 19 |
community mental | 19 |
cell transfusion | 19 |
infant mortality | 19 |
service encounter | 19 |
competitive advantage | 19 |
new service | 19 |
health records | 19 |
quality management | 19 |
social network | 19 |
care needs | 19 |
results suggest | 19 |
supplementary material | 19 |
harm reduction | 19 |
people living | 19 |
user generated | 19 |
voluntary blood | 19 |
sample size | 19 |
infectious disease | 19 |
blood sample | 19 |
evidence graph | 19 |
peripheral blood | 19 |
results show | 19 |
nucleic acid | 19 |
different levels | 18 |
services within | 18 |
community services | 18 |
platelet units | 18 |
service encounters | 18 |
pharmaceutical care | 18 |
research project | 18 |
services sector | 18 |
data entry | 18 |
generation sequencing | 18 |
atlantic core | 18 |
stem cells | 18 |
digital service | 18 |
serum ferritin | 18 |
quality improvement | 18 |
children aged | 18 |
clinical significance | 18 |
national level | 18 |
respiratory syndrome | 18 |
reactive results | 18 |
public service | 18 |
care facilities | 18 |
selection criteria | 18 |
urban tertiarization | 18 |
service will | 18 |
patient care | 18 |
even though | 18 |
indirect antiglobulin | 18 |
city center | 18 |
platelet concentrate | 18 |
service user | 18 |
creative commons | 18 |
see table | 18 |
young people | 18 |
customer experience | 18 |
significantly increased | 18 |
additive solution | 18 |
packed red | 18 |
blood volume | 18 |
services production | 18 |
medical abortion | 18 |
outreach care | 18 |
natural language | 17 |
cardiac surgery | 17 |
positive relationship | 17 |
conceptual model | 17 |
healthcare accessibility | 17 |
pathogen inactivation | 17 |
total effect | 17 |
positive samples | 17 |
made available | 17 |
amino acid | 17 |
frozen plasma | 17 |
healthcare professionals | 17 |
digital transformation | 17 |
positive impact | 17 |
heart failure | 17 |
general health | 17 |
rhd positive | 17 |
ae ml | 17 |
patient blood | 17 |
new technologies | 17 |
urban settings | 17 |
transfused patients | 17 |
donor health | 17 |
surveillance system | 17 |
hb level | 17 |
supplementary report | 17 |
year period | 17 |
strategic planning | 17 |
cd cells | 17 |
healthcare delivery | 17 |
architect i | 17 |
face contacts | 17 |
transfusion practices | 17 |
new donors | 17 |
medical records | 17 |
business activity | 17 |
ethical issues | 17 |
york city | 17 |
factors like | 17 |
industrial production | 17 |
high quality | 17 |
ethnic minority | 17 |
two years | 17 |
mindspot clinic | 17 |
benefi ts | 17 |
neural networks | 17 |
automated blood | 17 |
research team | 16 |
donate blood | 16 |
high school | 16 |
managed care | 16 |
high frequency | 16 |
university hospital | 16 |
blood type | 16 |
replacement therapy | 16 |
media analytics | 16 |
will help | 16 |
african american | 16 |
patients receiving | 16 |
previous studies | 16 |
two different | 16 |
plasma exchange | 16 |
child health | 16 |
bleeding patients | 16 |
recent years | 16 |
cervical cancer | 16 |
severe acute | 16 |
spectra optia | 16 |
empirical study | 16 |
public sector | 16 |
tradable goods | 16 |
among people | 16 |
care service | 16 |
retrospective study | 16 |
technology adoption | 16 |
southeast asian | 16 |
transfusion practice | 16 |
first step | 16 |
bacterial growth | 16 |
digital services | 16 |
cold storage | 16 |
physical health | 16 |
i sr | 16 |
medical college | 16 |
bike sharing | 16 |
data sets | 16 |
based research | 16 |
hiv positive | 16 |
rhd typing | 16 |
may lead | 16 |
climate issues | 16 |
residual risk | 16 |
fully automated | 16 |
massive transfusion | 16 |
sentiment analysis | 16 |
media platforms | 16 |
reproductive health | 16 |
spatial accessibility | 16 |
increasing number | 15 |
fresh frozen | 15 |
results obtained | 15 |
bibliometric analysis | 15 |
results indicate | 15 |
six months | 15 |
health problem | 15 |
iron stores | 15 |
last decade | 15 |
transport system | 15 |
psychological distress | 15 |
tradable producer | 15 |
information regarding | 15 |
structural equation | 15 |
apheresis platelets | 15 |
urban communities | 15 |
bacterial contamination | 15 |
within days | 15 |
pretransfusion testing | 15 |
also found | 15 |
chronic inflammation | 15 |
business services | 15 |
topic modelling | 15 |
north america | 15 |
receipt platform | 15 |
regular blood | 15 |
mortality rates | 15 |
commonly used | 15 |
several studies | 15 |
high prevalence | 15 |
plasma samples | 15 |
pacific cities | 15 |
behavioral health | 15 |
standard deviation | 15 |
many people | 15 |
help us | 15 |
chronic diseases | 15 |
i believe | 15 |
catchment area | 15 |
bact alert | 15 |
patient experience | 15 |
renal failure | 15 |
local health | 15 |
positive effect | 15 |
tested using | 15 |
substance abuse | 15 |
network analysis | 15 |
per day | 15 |
economic restructuring | 15 |
study also | 15 |
intellectual structure | 15 |
health surveillance | 15 |
platelet yield | 15 |
rhd exon | 15 |
group systems | 15 |
health research | 15 |
hbv dna | 15 |
low probability | 15 |
human rights | 14 |
serological testing | 14 |
capacity building | 14 |
donor population | 14 |
study conducted | 14 |
per person | 14 |
language processing | 14 |
adult hope | 14 |
adverse effects | 14 |
regular donors | 14 |
buffy coat | 14 |
cd monoclonal | 14 |
outpatient services | 14 |
management system | 14 |
study will | 14 |
logistics customer | 14 |
iron overload | 14 |
cmv igg | 14 |
developed countries | 14 |
observational study | 14 |
hev rna | 14 |
pacific region | 14 |
collected data | 14 |
spatial planning | 14 |
service management | 14 |
camh conditions | 14 |
care systems | 14 |
donor blood | 14 |
mental healthcare | 14 |
large numbers | 14 |
health coverage | 14 |
cobe spectra | 14 |
dental service | 14 |
clinical trial | 14 |
healthcare systems | 14 |
per month | 14 |
donor recruitment | 14 |
best practices | 14 |
transfusion center | 14 |
donor screening | 14 |
platelet products | 14 |
donor safety | 14 |
cloud computing | 14 |
patients received | 14 |
perceived usefulness | 14 |
global networks | 14 |
data will | 14 |
transfusion transmitted | 14 |
iron depletion | 14 |
new urban | 14 |
past years | 14 |
local community | 14 |
missing data | 14 |
health applications | 14 |
iv iron | 14 |
platelet transfusions | 14 |
care provision | 14 |
transfusion recipients | 14 |
patient satisfaction | 14 |
business models | 14 |
therapeutic plasma | 14 |
study showed | 14 |
homeless people | 14 |
polymerase chain | 14 |
health providers | 14 |
perceived ease | 14 |
normal rhd | 14 |
next generation | 14 |
tube method | 14 |
exploratory study | 14 |
compatible blood | 14 |
positive donors | 14 |
hope scale | 14 |
order cycle | 14 |
rhd variants | 14 |
health data | 13 |
three different | 13 |
measurement feedback | 13 |
collect data | 13 |
additional file | 13 |
contact tracing | 13 |
pathogen reduction | 13 |
river delta | 13 |
based services | 13 |
system actors | 13 |
new health | 13 |
previous research | 13 |
growth rate | 13 |
advanced service | 13 |
cell antigens | 13 |
ag ab | 13 |
month deferral | 13 |
antibody detection | 13 |
family planning | 13 |
cord blood | 13 |
scd patients | 13 |
urban policy | 13 |
injection drug | 13 |
industry development | 13 |
media data | 13 |
study shows | 13 |
based care | 13 |
real world | 13 |
blood loss | 13 |
asian msm | 13 |
one year | 13 |
metropolitan areas | 13 |
effect sizes | 13 |
study included | 13 |
white blood | 13 |
also performed | 13 |
industries within | 13 |
pearl river | 13 |
platelet counts | 13 |
ai will | 13 |
media sites | 13 |
cohort study | 13 |
murshidabad district | 13 |
gene deletion | 13 |
among others | 13 |
analyzed using | 13 |
factors affecting | 13 |
higher education | 13 |
central government | 13 |
cell concentrates | 13 |
suburban areas | 13 |
using ai | 13 |
th anniversary | 13 |
care organizations | 13 |
donor return | 13 |
alpha architecture | 13 |
united kingdom | 13 |
years ago | 13 |
heme iron | 13 |
services process | 13 |
physical activity | 13 |
urban planning | 13 |
clinical outcomes | 13 |
citation analysis | 13 |
hiv ag | 13 |
copyright holder | 13 |
theoretical model | 13 |
evidence based | 13 |
pooled platelet | 13 |
random sample | 13 |
social influence | 13 |
infl uenza | 13 |
adverse outcomes | 13 |
social responsibility | 13 |
delphi method | 13 |
allowed us | 13 |
group antigen | 13 |
cell antibody | 13 |
european countries | 13 |
analysed using | 13 |
study aims | 13 |
antibody identification | 13 |
claims data | 13 |
transport services | 13 |
first study | 13 |
chain reaction | 13 |
different blood | 13 |
saharan africa | 13 |
limited resources | 13 |
donor retention | 13 |
will continue | 13 |
older adults | 13 |
sustainable development | 13 |
regions within | 13 |
social isolation | 13 |
qualitative study | 13 |
total population | 13 |
may suggest | 13 |
vox sanguinis | 13 |
signifi cant | 13 |
dg gel | 12 |
gene expression | 12 |
services work | 12 |
results showed | 12 |
drug abuse | 12 |
false positive | 12 |
health education | 12 |
will increase | 12 |
conceptual framework | 12 |
urban growth | 12 |
negative effect | 12 |
per unit | 12 |
significantly associated | 12 |
may include | 12 |
regional development | 12 |
vasovagal reactions | 12 |
supply chains | 12 |
may result | 12 |
services growth | 12 |
molecular basis | 12 |
mean hb | 12 |
direct antiglobulin | 12 |
operating procedures | 12 |
high incidence | 12 |
new healthcare | 12 |
routine use | 12 |
health treatment | 12 |
significant increase | 12 |
deaths per | 12 |
log iu | 12 |
data sources | 12 |
plasma transfusion | 12 |
factors associated | 12 |
prospective study | 12 |
study group | 12 |
ended questions | 12 |
target population | 12 |
data elements | 12 |
pacific city | 12 |
research field | 12 |
disease control | 12 |
financing strategies | 12 |
better understand | 12 |
community capacity | 12 |
step guide | 12 |
dependent variable | 12 |
industry growth | 12 |
lessons learned | 12 |
cost effectiveness | 12 |
high probability | 12 |
statistical methods | 12 |
hardship status | 12 |
improve patient | 12 |
analysis showed | 12 |
comparative study | 12 |
systematic literature | 12 |
chinese social | 12 |
hla antibodies | 12 |
vitro quality | 12 |
health programs | 12 |
site suitability | 12 |
health centers | 12 |
confidence interval | 12 |
health authorities | 12 |
qualitative research | 12 |
treated cells | 12 |
cycle time | 12 |
food insecurity | 12 |
cities within | 12 |
decision support | 12 |
music therapists | 12 |
safe abortion | 12 |
market share | 12 |
health disparities | 12 |
fetal rhd | 12 |
per capita | 12 |
patient outcomes | 12 |
drug treatment | 12 |
sexually transmitted | 12 |
health effects | 12 |
basic services | 12 |
labour force | 12 |
old female | 12 |
iron status | 12 |
cost effective | 12 |
digital mental | 12 |
production systems | 12 |
economic base | 12 |
global city | 12 |
findings suggest | 12 |
abo typing | 12 |
will describe | 12 |
data obtained | 12 |
service usage | 12 |
proposed model | 12 |
will improve | 12 |
starting point | 12 |
change within | 12 |
persons engaged | 11 |
will require | 11 |
clinical symptoms | 11 |
development control | 11 |
demographic characteristics | 11 |
also observed | 11 |
mixed methods | 11 |
component preparation | 11 |
pediatric patients | 11 |
marker variable | 11 |
european union | 11 |
high smartness | 11 |
health institutions | 11 |
care delivery | 11 |
using different | 11 |
therapy professionals | 11 |
research agenda | 11 |
electronic medical | 11 |
ethnic groups | 11 |
health field | 11 |
health survey | 11 |
geographic information | 11 |
reactive samples | 11 |
research methodology | 11 |
blood system | 11 |
district medical | 11 |
protective equipment | 11 |
different types | 11 |
among first | 11 |
patient relationship | 11 |
blood processing | 11 |
social workers | 11 |
cancer patients | 11 |
live births | 11 |
psychosocial interventions | 11 |
prenatal care | 11 |
abo genotyping | 11 |
relatively high | 11 |
single nucleotide | 11 |
current study | 11 |
document logistics | 11 |
primary healthcare | 11 |
greater odds | 11 |
surveillance systems | 11 |
rhd variant | 11 |
research question | 11 |
storage time | 11 |
healthcare workers | 11 |
industrialized countries | 11 |
meals purchased | 11 |
psychological empowerment | 11 |
screening tests | 11 |
local governments | 11 |
apheresis platelet | 11 |
median number | 11 |
service uses | 11 |
climate science | 11 |
three years | 11 |
technological barriers | 11 |
also used | 11 |
pharmacy practice | 11 |
rapid growth | 11 |
may need | 11 |
adverse reaction | 11 |
usage experience | 11 |
among women | 11 |
hemoglobin level | 11 |
take advantage | 11 |
platelet antigens | 11 |
cross match | 11 |
global economy | 11 |
global cities | 11 |
social work | 11 |
plasma dna | 11 |
test results | 11 |
care professionals | 11 |
great deal | 11 |
buffy coats | 11 |
local level | 11 |
service workers | 11 |
creative services | 11 |
needed services | 11 |
smoking cessation | 11 |
support services | 11 |
suitable site | 11 |
negative impact | 11 |
risk management | 11 |
one case | 11 |
take place | 11 |
services will | 11 |
using multiple | 11 |
blood centres | 11 |
ethics committee | 11 |
evidence base | 11 |
international license | 11 |
economic growth | 11 |
unwanted sexual | 11 |
public transit | 11 |
service efficiency | 11 |
analysis revealed | 11 |
specific antibodies | 11 |
paper will | 11 |
behavioral intention | 11 |
available data | 11 |
adverse event | 11 |
information risk | 11 |
prt system | 11 |
new business | 11 |
regression models | 11 |
screening assays | 10 |
analysis using | 10 |
alternative services | 10 |
cd count | 10 |
hbv infection | 10 |
district health | 10 |
detected variant | 10 |
voluntary non | 10 |
significantly reduced | 10 |
blood screening | 10 |
bombay phenotype | 10 |
urgent need | 10 |
chronic disease | 10 |
antibody positive | 10 |
first months | 10 |
screening test | 10 |
based health | 10 |
transfusion related | 10 |
results indicated | 10 |
service science | 10 |
affective engagement | 10 |
recent syphilis | 10 |
depressive symptoms | 10 |
data analytics | 10 |
randomly selected | 10 |
one patient | 10 |
mortality rate | 10 |
disease surveillance | 10 |
ex vivo | 10 |
urban area | 10 |
point likert | 10 |
many patients | 10 |
care workers | 10 |
screening assessment | 10 |
acute care | 10 |
payment service | 10 |
samples tested | 10 |
likert scale | 10 |
inaccessible areas | 10 |
older people | 10 |
significant proportion | 10 |
based treatment | 10 |
literature indicates | 10 |
national government | 10 |
tube methods | 10 |
antibody screen | 10 |
public administration | 10 |
new approach | 10 |
topic models | 10 |
pregnant woman | 10 |
higher number | 10 |
relatively new | 10 |
negative pregnant | 10 |
potential risk | 10 |
gel cards | 10 |
forward type | 10 |
internal consistency | 10 |
rich plasma | 10 |
united nations | 10 |
services may | 10 |
working age | 10 |
health expenditure | 10 |
cloud service | 10 |
fort bragg | 10 |
common practice | 10 |
management accounting | 10 |
clinical transfusion | 10 |
blood culture | 10 |
allele frequencies | 10 |
haemolytic transfusion | 10 |
hiv prevalence | 10 |
industrial restructuring | 10 |
communicable diseases | 10 |
general practitioners | 10 |
will discuss | 10 |
preoperative anemia | 10 |
new system | 10 |
economic status | 10 |
renal replacement | 10 |
treatment outcomes | 10 |
urban economic | 10 |
seven factors | 10 |
care settings | 10 |
cost analysis | 10 |
specific primers | 10 |
social hardship | 10 |
remote working | 10 |
group alleles | 10 |
factor analysis | 10 |
office development | 10 |
three months | 10 |
circulatory overload | 10 |
local planning | 10 |
coronavirus disease | 10 |
clinical care | 10 |
multiple regression | 10 |
molecular typing | 10 |
metropolitan core | 10 |
south african | 10 |
standard operating | 10 |
civil society | 10 |
less likely | 10 |
rbc transfusions | 10 |
industrial structure | 10 |
sheep pcs | 10 |
higher rates | 10 |
million donations | 10 |
may affect | 10 |
heart disease | 10 |
empirical research | 10 |
health financing | 10 |
adoption literature | 10 |
sexual health | 10 |
circular economy | 10 |
better health | 10 |
quality services | 10 |
new immigrants | 10 |
rhd weak | 10 |
transfusion protocol | 10 |
contact hours | 10 |
donating blood | 10 |
russian federation | 10 |
sexual abuse | 10 |
significant effect | 10 |
structured interviews | 10 |
air pollution | 10 |
many studies | 10 |
samples collected | 10 |
mental illnesses | 10 |
mobile application | 10 |
better understanding | 10 |
science research | 10 |
increased levels | 10 |
community participation | 10 |
growing number | 10 |
pg ml | 10 |
available online | 10 |
overall customer | 10 |
crack users | 10 |
table shows | 10 |
providing services | 10 |
improve health | 10 |
times per | 10 |
health risks | 10 |
mohamed ibrahim | 10 |
service functions | 10 |
hla typing | 10 |
descriptive statistics | 10 |
waste management | 10 |
medical staff | 10 |
published data | 10 |
monoclonal antibodies | 10 |
food outlet | 10 |
feedback systems | 10 |
evidence graphs | 10 |
among children | 10 |
anniversary celebration | 10 |
specific health | 10 |
institutional review | 9 |
low level | 9 |
real estate | 9 |
delphi survey | 9 |
often used | 9 |
urban social | 9 |
previously reported | 9 |
parameter estimates | 9 |
platelet storage | 9 |
using data | 9 |
care triage | 9 |
management systems | 9 |
making approach | 9 |
outpatient care | 9 |
older adult | 9 |
medical institution | 9 |
human services | 9 |
donor adverse | 9 |
mirasol treated | 9 |
received ch | 9 |
patient identification | 9 |
emergency department | 9 |
care hospital | 9 |
abo antigens | 9 |
stored platelets | 9 |
sample id | 9 |
donation site | 9 |
suitability analysis | 9 |
social science | 9 |
severe transfusion | 9 |
vital role | 9 |
knowledge translation | 9 |
hemolytic anemia | 9 |
grocery store | 9 |
improve quality | 9 |
cross blood | 9 |
eastern europe | 9 |
disease prevention | 9 |
time pcr | 9 |
consultation service | 9 |
cd hematopoietic | 9 |
rbc blood | 9 |
rare donor | 9 |
unexpected antibody | 9 |
services using | 9 |
healthy donors | 9 |
using alinity | 9 |
monoclonal anti | 9 |
reverse type | 9 |
services development | 9 |
digital health | 9 |
empowerment scale | 9 |
fi nancial | 9 |
adverse transfusion | 9 |
compatibility testing | 9 |
viral load | 9 |
deferred donors | 9 |
commons licence | 9 |
production process | 9 |
chinese cities | 9 |
one way | 9 |
hybrid decision | 9 |
intermediate services | 9 |
future studies | 9 |
provide feedback | 9 |
hematological patients | 9 |
based service | 9 |
use cases | 9 |
response rate | 9 |
last two | 9 |
donated blood | 9 |
action plan | 9 |
polysubstance use | 9 |
study suggests | 9 |
quality assessment | 9 |
past two | 9 |
social structure | 9 |
service consumption | 9 |
health practice | 9 |
confirmed positive | 9 |
per week | 9 |
research literature | 9 |
pm shift | 9 |
peer review | 9 |
health indicators | 9 |
human platelet | 9 |
public opinion | 9 |
tested positive | 9 |
deep neural | 9 |
health management | 9 |
purchased away | 9 |
using two | 9 |
i ii | 9 |
new economy | 9 |
post transfusion | 9 |
routine testing | 9 |
based climate | 9 |
will allow | 9 |
lower levels | 9 |
posted september | 9 |
particular interest | 9 |
social change | 9 |
primary eye | 9 |
risk behaviours | 9 |
units per | 9 |
staff working | 9 |
paper waste | 9 |
world bank | 9 |
finger prick | 9 |
payment services | 9 |
also determined | 9 |
use disorders | 9 |
personal communication | 9 |
postpartum hemorrhage | 9 |
business management | 9 |
month period | 9 |
collaboration analysis | 9 |
abo discrepancies | 9 |
access health | 9 |
platelet aggregation | 9 |
large amounts | 9 |
repetitive transcranial | 9 |
community development | 9 |
laboratory tests | 9 |
positive dat | 9 |
key informants | 9 |
health related | 9 |
precision psychiatry | 9 |
body weight | 9 |
version posted | 9 |
immunomodulatory mediators | 9 |
commercially available | 9 |
blood bags | 9 |
order processing | 9 |
social service | 9 |
hla class | 9 |
delayed transfusion | 9 |
data set | 9 |
delivery time | 9 |
wide variety | 9 |
business opportunities | 9 |
additional information | 9 |
three main | 9 |
regional blood | 9 |
decreased significantly | 9 |
will become | 9 |
accessibility index | 9 |
hemopathic patients | 9 |
discrepant results | 9 |
hemoglobin levels | 9 |
entries high | 9 |
negative results | 9 |
deferral rate | 9 |
total blood | 9 |
existing health | 9 |
intron enhancer | 9 |
without agitation | 9 |
health agency | 9 |
quality care | 9 |
development strategies | 9 |
lived experience | 9 |
associated cost | 9 |
urban centres | 9 |
two weeks | 9 |
gold standard | 9 |
past months | 9 |
prevalence among | 9 |
cardiovascular disease | 9 |
profiler component | 9 |
within min | 9 |
data source | 9 |
communication channel | 9 |
mediating role | 9 |
supply management | 9 |
laboratory services | 9 |
health policies | 9 |
built environment | 9 |
reactive donors | 9 |
haemorrhagic shock | 9 |
developing world | 9 |
review board | 9 |
smartness characteristics | 9 |
transfusion support | 9 |
local authorities | 9 |
providing information | 9 |
time period | 9 |
observational data | 9 |
mg ml | 9 |
blood establishments | 9 |
many developing | 9 |
longitudinal data | 9 |
child mortality | 9 |
rare blood | 9 |
health facility | 9 |
agglutination technology | 9 |
see chapter | 9 |
community based | 9 |
total score | 9 |
educational level | 9 |
decision makers | 9 |
author funder | 9 |
quantitative data | 9 |
magnetic stimulation | 9 |
ethical approval | 9 |
community partners | 9 |
central role | 9 |
healthcare sector | 9 |
mass index | 9 |
rh blood | 9 |
information collected | 9 |
private partnerships | 9 |
abo gene | 9 |
cost per | 9 |
effective interventions | 9 |
two units | 9 |
section describes | 9 |
risk assessment | 9 |
global health | 9 |
granted medrxiv | 9 |
effi cient | 9 |
food security | 9 |
transcranial magnetic | 9 |
controlled trial | 8 |
ecological momentary | 8 |
molecular methods | 8 |
adverse effect | 8 |
sid patients | 8 |
previously described | 8 |
using spss | 8 |
lung injury | 8 |
first half | 8 |
human immunodeficiency | 8 |
storage conditions | 8 |
district hospital | 8 |
surveillance application | 8 |
euclidean distance | 8 |
dna sequencing | 8 |
research model | 8 |
key stakeholders | 8 |
transfusion strategies | 8 |
universal health | 8 |
women living | 8 |
high need | 8 |
iot devices | 8 |
age years | 8 |
confl ict | 8 |
corporate control | 8 |
large extent | 8 |
ionized calcium | 8 |
temporary deferral | 8 |
sentiment mining | 8 |
three groups | 8 |
randomly assigned | 8 |
homozygous mutation | 8 |
goods sector | 8 |
voluntary sector | 8 |
one meal | 8 |
care utilization | 8 |
two samples | 8 |
delayed hemolytic | 8 |
outcome indicators | 8 |
many cases | 8 |
standard serological | 8 |
work environment | 8 |
also provide | 8 |
social sciences | 8 |
kong economy | 8 |
criminal justice | 8 |
health agencies | 8 |
abo system | 8 |
class i | 8 |
customer demands | 8 |
study using | 8 |
global burden | 8 |
st century | 8 |
scientific collaboration | 8 |
effective treatment | 8 |
sexual experiences | 8 |
major challenge | 8 |
pollen season | 8 |
aok nordost | 8 |
patient population | 8 |
pharmacy services | 8 |
emergency departments | 8 |
product utilization | 8 |
transport systems | 8 |
igg assay | 8 |
search terms | 8 |
apheresis donors | 8 |
current health | 8 |
health equalization | 8 |
new ways | 8 |
policy development | 8 |
social exchange | 8 |
study provides | 8 |
root causes | 8 |
maximal oxygen | 8 |
communication skills | 8 |
public hospitals | 8 |
two patients | 8 |
video calls | 8 |
research center | 8 |
care resources | 8 |
oncologic care | 8 |
negative donors | 8 |
special schools | 8 |
timely manner | 8 |
squ students | 8 |
results will | 8 |
also showed | 8 |
among repeat | 8 |
group ii | 8 |
treatment effects | 8 |
determined using | 8 |
cell line | 8 |
cancer screening | 8 |
variant alleles | 8 |
pilot project | 8 |
yellow line | 8 |
blood chimerism | 8 |
well known | 8 |
new blood | 8 |
frequency antigens | 8 |
oxygen uptake | 8 |
young male | 8 |
will contribute | 8 |
improving population | 8 |
village doctors | 8 |
theoretical framework | 8 |
routine care | 8 |
laboratory service | 8 |
solid waste | 8 |
hb values | 8 |
customer behavior | 8 |
also reported | 8 |
medication use | 8 |
online retail | 8 |
thalassemia major | 8 |
transfusion events | 8 |
local policy | 8 |
mani chouk | 8 |
problem solving | 8 |
hev igg | 8 |
investigate whether | 8 |
allele abo | 8 |
health reform | 8 |
oral iron | 8 |
female donor | 8 |
neurological tumours | 8 |
attitude towards | 8 |
user acceptance | 8 |
genetic basis | 8 |
quality healthcare | 8 |
floating catchment | 8 |
climate information | 8 |
noted earlier | 8 |
blood unit | 8 |
high degree | 8 |
proposed system | 8 |
study area | 8 |
east asia | 8 |
allogeneic donors | 8 |
strongly agreed | 8 |
improved health | 8 |
times higher | 8 |
anxiety disorder | 8 |
central city | 8 |
performance analysis | 8 |
springer nature | 8 |
spatial distribution | 8 |
daily living | 8 |
participatory research | 8 |
relative accessibility | 8 |
higher accessibility | 8 |
western pomerania | 8 |
common method | 8 |
sigma metrics | 8 |
north west | 8 |
safe sex | 8 |
predictive value | 8 |
negative blood | 8 |
effective way | 8 |
cultural economy | 8 |
done using | 8 |
days storage | 8 |
social development | 8 |
hiv incidence | 8 |
needle exchange | 8 |
quality indicators | 8 |
gr dl | 8 |
routine blood | 8 |
customer perceptions | 8 |
quality parameters | 8 |
health doi | 8 |
rhd antigen | 8 |
saudi arabia | 8 |
one hand | 8 |
poor health | 8 |
great importance | 8 |
lactate production | 8 |
humanistic care | 8 |
surveillance data | 8 |
pharmaceutical services | 8 |
care clinics | 8 |
flow cytometric | 8 |
medical treatment | 8 |
abortion care | 8 |
hospital transfusion | 8 |
many different | 8 |
measured using | 8 |
second half | 8 |
job satisfaction | 8 |
one approach | 8 |
using ml | 8 |
variant rhd | 8 |
psychological treatment | 8 |
human resource | 8 |
receipt solution | 8 |
leading cause | 8 |
two main | 8 |
research design | 8 |
allergic reactions | 8 |
different technologies | 8 |
developed using | 8 |
abuse treatment | 8 |
making process | 8 |
local population | 8 |
positive correlation | 8 |
federal states | 8 |
metropolitan space | 8 |
increasing complexity | 8 |
cloud platform | 8 |
linear combination | 8 |
personal protective | 8 |
bb mode | 8 |
allogeneic blood | 8 |
smartness scenario | 8 |
hormone intake | 8 |
perceived utility | 8 |
gel selection | 8 |
may provide | 8 |
behavioral constructs | 8 |
th march | 8 |
cognitive engagement | 8 |
vast majority | 8 |
platelet cd | 8 |
western blot | 8 |
genotyping results | 8 |
public management | 8 |
policy approaches | 8 |
peer support | 8 |
health expenditures | 8 |
time consuming | 8 |
rhd alleles | 8 |
serological typing | 8 |
high throughput | 8 |
customers need | 8 |
maternal plasma | 8 |
low smartness | 8 |
thematic analysis | 8 |
entries conclusion | 8 |
delphi study | 8 |
study found | 8 |
blood processed | 8 |
service centres | 8 |
effect size | 8 |
total factor | 8 |
provide information | 8 |
royal college | 8 |
case report | 8 |
haemolytic disease | 8 |
precision mental | 8 |
assessed using | 8 |
media marketing | 8 |
data processing | 8 |
dat positive | 8 |
last donation | 8 |
treatment services | 8 |
clinical data | 8 |
member states | 8 |
journal pre | 8 |
research methods | 8 |
described earlier | 8 |
randomised controlled | 8 |
service needs | 8 |
based methods | 8 |
operating room | 8 |
apheresis procedures | 8 |
preliminary results | 8 |
health concerns | 8 |
make decisions | 8 |
based solutions | 8 |
obstetric services | 8 |
prevalence antigen | 8 |
low ferritin | 8 |
shelf life | 8 |
urban centers | 8 |
flow rate | 8 |
methods used | 8 |
health record | 8 |
related adverse | 8 |
adult patients | 8 |
camh service | 8 |
among customers | 7 |
large part | 7 |
rh antigens | 7 |
medical research | 7 |
patient involvement | 7 |
i want | 7 |
increased access | 7 |
item scale | 7 |
based participatory | 7 |
donor recruiter | 7 |
among asia | 7 |
independently associated | 7 |
conversational agents | 7 |
cvd risk | 7 |
health infoway | 7 |
service development | 7 |
plasma donors | 7 |
laboratory network | 7 |
care act | 7 |
manual method | 7 |
added value | 7 |
sex hormone | 7 |
current state | 7 |
healthcare centres | 7 |
oxidative stress | 7 |
disease severity | 7 |
local communities | 7 |
accel version | 7 |
community settings | 7 |
old atlantic | 7 |
transfusion sample | 7 |
patient engagement | 7 |
irregular antibody | 7 |
care unit | 7 |
service sectors | 7 |
also important | 7 |
typing discrepancy | 7 |
ideal best | 7 |
risk reduction | 7 |
high rates | 7 |
severe anemia | 7 |
hb value | 7 |
data protection | 7 |
clinical decision | 7 |
ai may | 7 |
health inequalities | 7 |
negative impacts | 7 |
canada health | 7 |
routine abo | 7 |
national governments | 7 |
donation sites | 7 |
may cause | 7 |
meal prepared | 7 |
world cities | 7 |
infectious dose | 7 |
hospital blood | 7 |
psychiatric disorders | 7 |
many asian | 7 |
low risk | 7 |
health measures | 7 |
odds ratio | 7 |
data showed | 7 |
chemokine scavenging | 7 |
terrorist attacks | 7 |
long time | 7 |
ferritin level | 7 |
worm infections | 7 |
illicit drug | 7 |
local government | 7 |
repeat reactive | 7 |
maternal rhd | 7 |
black infant | 7 |
studies carried | 7 |
transit system | 7 |
ml min | 7 |
southern china | 7 |
amajuba district | 7 |
occupancy rate | 7 |
downtown toronto | 7 |
using alternative | 7 |
gel method | 7 |
discordant results | 7 |
healthcare provider | 7 |
priority setting | 7 |
clinical studies | 7 |
five years | 7 |
research directions | 7 |
hybrid model | 7 |
affordable care | 7 |
physician visits | 7 |
several countries | 7 |
findings indicate | 7 |
international society | 7 |
accelerated tertiarization | 7 |
use ai | 7 |
transfusion policy | 7 |
past decade | 7 |
average number | 7 |
inventory management | 7 |
crisis services | 7 |
entry point | 7 |
weak positive | 7 |
transportation business | 7 |
hcv screening | 7 |
cultural industries | 7 |
allogeneic hematopoietic | 7 |
offline retailers | 7 |
large data | 7 |
transfusion within | 7 |
west bengal | 7 |
expiry date | 7 |
cross sectional | 7 |
amongst respondents | 7 |
negative phenotype | 7 |
lutheran glycoprotein | 7 |
will affect | 7 |
domestic product | 7 |
rh null | 7 |
among different | 7 |
hiv rr | 7 |
study may | 7 |
platelet activation | 7 |
mean score | 7 |
also identified | 7 |
neonatal alloimmune | 7 |
rhdi hdfn | 7 |
major depressive | 7 |
policy research | 7 |
rna positive | 7 |
studies showed | 7 |
population density | 7 |
per patient | 7 |
square test | 7 |
challenges associated | 7 |
without compromising | 7 |
environmental health | 7 |
organizational structure | 7 |
retail sme | 7 |
research ethics | 7 |
street health | 7 |
binding sites | 7 |
data citation | 7 |
iron intake | 7 |
positive cases | 7 |
low hemoglobin | 7 |
social costs | 7 |
remains neutral | 7 |
services based | 7 |
will include | 7 |
six sigma | 7 |
cardiovascular diseases | 7 |
african descent | 7 |
specimen collection | 7 |
blood banking | 7 |
welfare system | 7 |
using flow | 7 |
inferential analysis | 7 |
higher frequency | 7 |
based practice | 7 |
sterile syringes | 7 |
minority immigrants | 7 |
hours per | 7 |
transfusion history | 7 |
small number | 7 |
severe mental | 7 |
cloud brokering | 7 |
chart review | 7 |
tfp growth | 7 |
genomes project | 7 |
incidence antigen | 7 |
research process | 7 |
data model | 7 |
transfusion guidelines | 7 |
general practitioner | 7 |
multiple myeloma | 7 |
economically disadvantaged | 7 |
spss software | 7 |
seek help | 7 |
study design | 7 |
asia type | 7 |
nature remains | 7 |
zikv rna | 7 |
antibody specificities | 7 |
human pcs | 7 |
closely monitored | 7 |
infection among | 7 |
seven days | 7 |
consensus among | 7 |
program evaluation | 7 |
pgy group | 7 |
sought help | 7 |
transfused units | 7 |
fi rst | 7 |
healthy blood | 7 |
group interviews | 7 |
bus service | 7 |
well established | 7 |
tell us | 7 |
pbpc products | 7 |
among patients | 7 |
sample sizes | 7 |
strategic management | 7 |
create new | 7 |
body mass | 7 |
rhce ce | 7 |
syndromic surveillance | 7 |
clinical efficacy | 7 |
medication dispensing | 7 |
donation attempt | 7 |
also tested | 7 |
health centres | 7 |
consistent results | 7 |
severe cases | 7 |
chinese population | 7 |
short term | 7 |
health solutions | 7 |
deferral period | 7 |
health organizations | 7 |
engagement dimensions | 7 |
pharmacy practices | 7 |
integral part | 7 |
care organization | 7 |
operational efficiency | 7 |
remunerated blood | 7 |
data mining | 7 |
go beyond | 7 |
prolonged storage | 7 |
among older | 7 |
randomized controlled | 7 |
expectational probability | 7 |
institutional affiliations | 7 |
hiv disease | 7 |
irregular antibodies | 7 |
myeloid leukemia | 7 |
prenatal testing | 7 |
authorized users | 7 |
free dna | 7 |
rhd exons | 7 |
included studies | 7 |
survey results | 7 |
physical environment | 7 |
note springer | 7 |
research suggests | 7 |
one donor | 7 |
arachidonic acid | 7 |
increased mortality | 7 |
gateway roles | 7 |
cfu cm | 7 |
effective use | 7 |
working hours | 7 |
linear regression | 7 |
multiple transfusions | 7 |
therapy sessions | 7 |
see appendix | 7 |
tpe procedures | 7 |
jurisdictional claims | 7 |
per procedure | 7 |
abbott alinity | 7 |
clinical outcome | 7 |
negative comments | 7 |
highest rates | 7 |
service production | 7 |
service activities | 7 |
blood establishment | 7 |
study population | 7 |
group matching | 7 |
smart home | 7 |
second phase | 7 |
provide better | 7 |
observed among | 7 |
limited availability | 7 |
new approaches | 7 |
obstetrical services | 7 |
high impact | 7 |
metadata service | 7 |
inpatient service | 7 |
also significantly | 7 |
four measured | 7 |
way anova | 7 |
negative samples | 7 |
may require | 7 |
per test | 7 |
health apps | 7 |
hematology analyzer | 7 |
land transport | 7 |
also include | 7 |
working groups | 7 |
interim platelet | 7 |
world city | 7 |
next donation | 7 |
amustaline gsh | 7 |
positive rate | 7 |
hev infection | 7 |
host disease | 7 |
additional data | 7 |
gross domestic | 7 |
triage criteria | 7 |
significant number | 7 |
logistics industry | 7 |
eye drops | 7 |
universal access | 7 |
using social | 7 |
capital stock | 7 |
international collaboration | 7 |
analysis shows | 7 |
intervention group | 7 |
life expectancy | 7 |
delphi rounds | 7 |
first round | 7 |
pregnant donors | 7 |
metropolitan cities | 7 |
different countries | 7 |
proximal promoter | 7 |
increasingly used | 7 |
service coverage | 7 |
ae standard | 7 |
mg dl | 7 |
per live | 7 |
land cover | 7 |
test units | 7 |
use social | 7 |
arv use | 7 |
clinically important | 7 |
one third | 7 |
loss function | 7 |
early detection | 7 |
many years | 7 |
communication platform | 7 |
drug therapy | 7 |
collected using | 7 |
use video | 7 |
without clinical | 7 |
highly tertiarized | 7 |
capital city | 7 |
significant reduction | 7 |
donation interval | 7 |
organ failure | 7 |
data indicate | 7 |
pharmacists must | 7 |
stroke prevention | 7 |
science mapping | 7 |
intrusiveness perceptions | 7 |
measured indicators | 7 |
service business | 7 |
also help | 7 |
negative effects | 7 |
final manuscript | 7 |
based approach | 7 |
auto seds | 7 |
like cost | 7 |
prc unit | 7 |
equal access | 7 |
may help | 7 |
guiding principles | 7 |
bay area | 7 |
platelet additive | 7 |
factor named | 7 |
continuous flow | 7 |
beta thalassemia | 7 |
national video | 7 |
also provided | 7 |
providing camh | 7 |
growth factor | 7 |
planning commission | 7 |
cmnc spectra | 7 |
published maps | 7 |
authors concluded | 7 |
cloud solutions | 7 |
learning algorithms | 7 |
safety concerns | 7 |
empirical studies | 7 |
escherichia coli | 7 |
community involvement | 7 |
fit indices | 7 |
low levels | 7 |
core xt | 7 |
fit index | 7 |
will enable | 7 |
sensitivity analysis | 7 |
clinical condition | 7 |
nat screening | 7 |
decisions based | 7 |
depressive disorder | 7 |
group methodology | 7 |
immunodeficiency virus | 7 |
immune response | 7 |
communication channels | 7 |
enable us | 7 |
photochemical treatment | 7 |
male donor | 7 |
low education | 7 |
content volume | 7 |
human capital | 7 |
health center | 7 |
slightly higher | 7 |
plasma freezing | 7 |
return rates | 7 |
search strategy | 7 |
high growth | 7 |
cv ranged | 7 |
duffy blood | 7 |
rbc exchange | 7 |
analyses showed | 7 |
rbc donors | 7 |
may vary | 7 |
real time | 7 |
proxy deflator | 7 |
water transport | 7 |
care staff | 7 |
client contact | 7 |
disease outbreaks | 7 |
kuala lumpur | 7 |
middle class | 7 |
obstetric service | 7 |
therapy profession | 7 |
patients treated | 7 |
metropolitan regions | 7 |
ferritin testing | 7 |
laboratory workers | 7 |
identify factors | 7 |
future directions | 7 |
per donor | 7 |
mean ae | 7 |
disabled children | 7 |
tertiarization within | 7 |
inflammatory cytokines | 6 |
north american | 6 |
related issues | 6 |
research will | 6 |
panel cells | 6 |
health consequences | 6 |
major cause | 6 |
several factors | 6 |
reverse innovation | 6 |
data element | 6 |
little evidence | 6 |
high blood | 6 |
nursing home | 6 |
ordering prc | 6 |
recovery process | 6 |
early stages | 6 |
many others | 6 |
hev igm | 6 |
program planning | 6 |
splice junctions | 6 |
will explore | 6 |
purchase food | 6 |
weighted linear | 6 |
transfused platelets | 6 |
trend towards | 6 |
mobile blood | 6 |
previously tested | 6 |
service occupations | 6 |
hb increment | 6 |
system based | 6 |
family medicine | 6 |
clinical signs | 6 |
causal relationships | 6 |
directive ec | 6 |
birth control | 6 |
south korea | 6 |
integrated approach | 6 |
antimicrobial resistance | 6 |
contingency plans | 6 |
significantly different | 6 |
economic burden | 6 |
group ab | 6 |
policy implications | 6 |
ec directive | 6 |
antifungal activity | 6 |
daily caseloads | 6 |
positive group | 6 |
answered yes | 6 |
study participants | 6 |
social groups | 6 |
hiv follow | 6 |
general public | 6 |
unique identity | 6 |
one sample | 6 |
horwood anglim | 6 |
reported health | 6 |
leukocyte reduction | 6 |
intermediate service | 6 |
transfer payments | 6 |
inpatient care | 6 |
large proportion | 6 |
using automated | 6 |
data may | 6 |
apheresis collection | 6 |
bus stops | 6 |
transfusion transmission | 6 |
fair process | 6 |
abo subgroups | 6 |
qualitative content | 6 |
patient outcome | 6 |
red crescent | 6 |
resource planning | 6 |
interquartile range | 6 |
great potential | 6 |
retention rate | 6 |
equally important | 6 |
among young | 6 |
using aadhaar | 6 |
reminder message | 6 |
torres strait | 6 |
platelet loss | 6 |
health emergency | 6 |
potential solution | 6 |
different applications | 6 |
geographical information | 6 |
open access | 6 |
customer attitude | 6 |
donation screening | 6 |
will lead | 6 |
may contribute | 6 |
donor typing | 6 |
cd gene | 6 |
empirical investigation | 6 |
respiratory tract | 6 |
abo discrepancy | 6 |
hdfn due | 6 |
outcome measures | 6 |
concentrates derived | 6 |
specific services | 6 |
different categories | 6 |
rbc alloantibodies | 6 |
future donation | 6 |
marrow donors | 6 |
low latency | 6 |
national institutes | 6 |
del phenotype | 6 |
nhs blood | 6 |
premedication rate | 6 |
th century | 6 |
equation modeling | 6 |
china national | 6 |
product quality | 6 |
eating disorders | 6 |
african americans | 6 |
sex workers | 6 |
com apis | 6 |
feedback system | 6 |
among health | 6 |
home based | 6 |
repeated blood | 6 |
medical necessity | 6 |
competing interests | 6 |
cell donors | 6 |
randomized clinical | 6 |
community hospitals | 6 |
selection process | 6 |
first years | 6 |
ethics approval | 6 |
much lower | 6 |
two methods | 6 |
digitalization process | 6 |
different actors | 6 |
industry change | 6 |
specific anti | 6 |
operating costs | 6 |
apis fairscape | 6 |
nearly half | 6 |
among donors | 6 |
risk patients | 6 |
manufacturing industries | 6 |
transfusion models | 6 |
next days | 6 |
data points | 6 |
positive blood | 6 |
results also | 6 |
maternal mortality | 6 |
including mental | 6 |
prevention science | 6 |
ai approach | 6 |
within asia | 6 |
message server | 6 |
healthcare research | 6 |
regular health | 6 |
service environment | 6 |
staphylococcus aureus | 6 |
best way | 6 |
delivery options | 6 |
governmental organizations | 6 |
healthcare centre | 6 |
time series | 6 |
sexually abused | 6 |
overall health | 6 |
high cost | 6 |
travel times | 6 |
donation attempts | 6 |
obstetric care | 6 |
care advisors | 6 |
scenario study | 6 |
offi cials | 6 |
demographic factors | 6 |
transmitted diseases | 6 |
social networking | 6 |
urban dwellers | 6 |
maternal antibodies | 6 |
mainly due | 6 |
chain management | 6 |
south asia | 6 |
waiting time | 6 |
qualitative analysis | 6 |
water supply | 6 |
healthcare utilization | 6 |
baseline data | 6 |
aadhaar linked | 6 |
good governance | 6 |
complex therapy | 6 |
nat testing | 6 |
also collected | 6 |
camh care | 6 |
monolayer assay | 6 |
thalassemia patients | 6 |
dubai blood | 6 |
molecular testing | 6 |
research shows | 6 |
social determinants | 6 |
personalized services | 6 |
special needs | 6 |
centered care | 6 |
secondary testing | 6 |
pid patients | 6 |
er op | 6 |
group i | 6 |
rapid changes | 6 |
online version | 6 |
transcription factors | 6 |
see chapters | 6 |
cell reagents | 6 |
rhd el | 6 |
different contexts | 6 |
responsive transport | 6 |
also included | 6 |
known risk | 6 |
applied research | 6 |
male recipients | 6 |
old transfusion | 6 |
health nurses | 6 |
taking advantage | 6 |
specific needs | 6 |
middle income | 6 |
variant allele | 6 |
retrospective review | 6 |
online survey | 6 |
western europe | 6 |
free environments | 6 |
third party | 6 |
evaluation data | 6 |
public transportation | 6 |
incident hiv | 6 |
strategy development | 6 |
government health | 6 |
retail market | 6 |
common among | 6 |
lifestyle behaviors | 6 |
energy supply | 6 |
frequency antigen | 6 |
case management | 6 |
survey data | 6 |
application management | 6 |
reference laboratories | 6 |
receipt conceptual | 6 |
right time | 6 |
auxiliary nurse | 6 |
relevant information | 6 |
current blood | 6 |
traditional face | 6 |
social exclusion | 6 |
inconclusive results | 6 |
economic sectors | 6 |
life threatening | 6 |
limited access | 6 |
chi minh | 6 |
flexible transport | 6 |
continuous monitoring | 6 |
customer retention | 6 |
major public | 6 |
persistent postpartum | 6 |
typing results | 6 |
hh patients | 6 |
granulocyte transfusion | 6 |
cell antibodies | 6 |
public healthcare | 6 |
development strategy | 6 |
monocyte monolayer | 6 |
section discusses | 6 |
personal experience | 6 |
donor pool | 6 |
vending machines | 6 |
randomized trial | 6 |
east asian | 6 |
everyday life | 6 |
associated costs | 6 |
routine clinical | 6 |
coding sequence | 6 |
component therapy | 6 |
grounded theory | 6 |
health questionnaire | 6 |
behavioral customer | 6 |
hemoglobin derivatives | 6 |
high viral | 6 |
similar results | 6 |
first line | 6 |
relevant literature | 6 |
north shore | 6 |
op visits | 6 |
health challenges | 6 |
respectively ce | 6 |
knowledge scores | 6 |
analysis based | 6 |
transfusion platelet | 6 |
mobile applications | 6 |
mental status | 6 |
behavioural intention | 6 |
oral health | 6 |
artificial tears | 6 |
may become | 6 |
ethical standards | 6 |
services include | 6 |
critically ill | 6 |
young blood | 6 |
temporarily deferred | 6 |
new delhi | 6 |
new development | 6 |
eye syndrome | 6 |
patients without | 6 |
health issue | 6 |
th donation | 6 |
deferral reasons | 6 |
may serve | 6 |
research priorities | 6 |
mononuclear cells | 6 |
medicaid expansion | 6 |
abo incompatibility | 6 |
national guidelines | 6 |
platelet apheresis | 6 |
healthcare staff | 6 |
will take | 6 |
canadian street | 6 |
longer term | 6 |
cell transfusions | 6 |
criteria decision | 6 |
blood bag | 6 |
cervical mucus | 6 |
hla antibody | 6 |
various ways | 6 |
services used | 6 |
black women | 6 |
large urban | 6 |
bacterial infections | 6 |
residential settings | 6 |
january st | 6 |
alloantibody formation | 6 |
digital enabler | 6 |
consumer acceptance | 6 |
deeper understanding | 6 |
use disorder | 6 |
typing discrepancies | 6 |
national economic | 6 |
rhd zygosity | 6 |
safe transfusion | 6 |
just one | 6 |
iron deficient | 6 |
surveillance officers | 6 |
mean ce | 6 |
kir dl | 6 |
international transport | 6 |
public hospital | 6 |
use land | 6 |
dce dce | 6 |
improving mental | 6 |
korean population | 6 |
critical review | 6 |
medical record | 6 |
ai research | 6 |
vulnerable populations | 6 |
clerical errors | 6 |
central blood | 6 |
word analysis | 6 |
based industries | 6 |
buccal swab | 6 |
regional level | 6 |
clinical settings | 6 |
access control | 6 |
recent immigrants | 6 |
ho chi | 6 |
refl ect | 6 |
urban form | 6 |
samples showed | 6 |
present research | 6 |
national institute | 6 |
interim analysis | 6 |
platelet concentration | 6 |
ferritin ng | 6 |
donors increased | 6 |
ideal solution | 6 |
via email | 6 |
managed competition | 6 |
rhd beadchip | 6 |
logu ml | 6 |
community resources | 6 |
english language | 6 |
human needs | 6 |
factor payment | 6 |
average values | 6 |
poster presentation | 6 |
two donors | 6 |
openapi description | 6 |
within urban | 6 |
highest proportion | 6 |
transfusion laboratory | 6 |
elderly population | 6 |
last months | 6 |
costs associated | 6 |
employment status | 6 |
insert table | 6 |
three decades | 6 |
antigen typing | 6 |
information sharing | 6 |
neo iris | 6 |
clinical psychologist | 6 |
paper provides | 6 |
concentrated within | 6 |
blood centre | 6 |
sequence analysis | 6 |
patient populations | 6 |
storage lesion | 6 |
wb units | 6 |
novel coronavirus | 6 |
two research | 6 |
similar clinical | 6 |
first blood | 6 |
pacific sphere | 6 |
gmp mfi | 6 |
health team | 6 |
folic acid | 6 |
care facility | 6 |
fetal blood | 6 |
living conditions | 6 |
reports regarding | 6 |
control measures | 6 |
fair chances | 6 |
rh antigen | 6 |